{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:55:28Z","timestamp":1790229328904,"version":"4.1.0"},"reference-count":17,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"DOI":"10.1210\/jc.2008-1349","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T01:35:07Z","timestamp":1231896907000},"page":"1295-1301","source":"Crossref","is-referenced-by-count":64,"title":["Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors"],"prefix":"10.1210","volume":"94","author":[{"given":"Franc\u0327oise","family":"Montravers","sequence":"first","affiliation":[{"name":"Departments of Nuclear Medicine (F.M., K.K., V.N., V.H., J.-N.T.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun","family":"Kerrou","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (F.M., K.K., V.N., V.H., J.-N.T.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vale\u0301rie","family":"Nataf","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (F.M., K.K., V.N., V.H., J.-N.T.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Huchet","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (F.M., K.K., V.N., V.H., J.-N.T.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Lotz","sequence":"additional","affiliation":[{"name":"Oncology (J.-P.L.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ruszniewski","sequence":"additional","affiliation":[{"name":"Department of Hepatogastroenterology (P.Ru.), Beaujon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 92110 Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[{"name":"Department of Hepatogastroenterology (P.Ro.), Ambroise Pare\u0301 Hospital, Assistance Publique Ho\u0302pitaux de Paris, 92100 Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327oise","family":"Duron","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (F.D., P.B.), Saint-Antoine Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (F.D., P.B.), Saint-Antoine Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Didier","family":"Grange\u0301","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology (J.-D.G.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Houry","sequence":"additional","affiliation":[{"name":"Surgery (S.H.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Noe\u0308l","family":"Talbot","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (F.M., K.K., V.N., V.H., J.-N.T.), Tenon Hospital, Assistance Publique Ho\u0302pitaux de Paris, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113313123300_R1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.195.2.7724749","article-title":"Pancreatic neuroendocrine tumors: diagnosis with PET.","volume":"195","author":"Ahlstro\u0308m","year":"1995","journal-title":"Radiology"},{"key":"key\n\t\t\t\t2019041113313123300_R2","first-page":"1180","article-title":"F-DOPA as an amino acid tracer to detect brain tumors.","volume":"37","author":"Heiss","year":"1996","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","article-title":"Whole-body 18F DOPA PET for detection of gastrointestinal carcinoid tumors.","volume":"220","author":"Hoegerle","year":"2001","journal-title":"Radiology"},{"key":"key\n\t\t\t\t2019041113313123300_R4","first-page":"1161","article-title":"Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET.","volume":"45","author":"Becherer","year":"2004","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0242-6498(05)86163-2","article-title":"Tumeurs endocrines gastro-intestinales: particularite\u0301s morphologiques et clinico-pathologiques.","volume":"25","author":"Couvelard","year":"2005","journal-title":"Ann Pathol"},{"key":"key\n\t\t\t\t2019041113313123300_R6","first-page":"13","article-title":"Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.","volume":"44","author":"Rindi","year":"2000","journal-title":"Q J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R7","first-page":"61","article-title":"Histological typing of endocrine tumours","author":"Solcia","year":"2000","journal-title":"In: International histological classification of tumours. 2nd ed. Berlin, Heidelberg: Springer-Verlag;"},{"key":"key\n\t\t\t\t2019041113313123300_R8","first-page":"1139","article-title":"Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.","volume":"42","author":"Scho\u0308der","year":"2001","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R9","first-page":"586","article-title":"Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician\u2019s perspective.","volume":"42","author":"Meta","year":"2001","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R10","first-page":"752","article-title":"The impact of PET on the management of lung cancer: the referring physician\u2019s perspective.","volume":"43","author":"Seltzer","year":"2002","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0038-1632205","article-title":"Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.","volume":"38","author":"Hoegerle","year":"1999","journal-title":"Nuklearmedizin"},{"key":"key\n\t\t\t\t2019041113313123300_R12","first-page":"1455","article-title":"Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?","volume":"47","author":"Montravers","year":"2006","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2007.15.1126","article-title":"Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11c-5-hydroxy-tryptophan positron emission tomography.","volume":"26","author":"Koopmans","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113313123300_R14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2006-1479","article-title":"Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or \u03b2-cell hyperplasia in adult patients.","volume":"92","author":"Kauhanen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113313123300_R15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/diabetes.55.01.06.db05-1128","article-title":"Noninvasive diagnosis of focal hyperinsulinism of infancy with {lsqb;18F{rsqb;DOPA positron emission tomography.","volume":"55","author":"Otonkoski","year":"2006","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113313123300_R16","first-page":"560","article-title":"Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.","volume":"46","author":"Ribeiro","year":"2005","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113313123300_R17","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/jc.2007-1637","article-title":"Accuracy of {lsqb;18F{rsqb; fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.","volume":"92","author":"Hardy","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/4\/1295\/10806882\/jcem1295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T06:15:09Z","timestamp":1558073709000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/4\/1295\/2596460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-1349","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}